Home Health Care News May 31, 2024
In early May, it was reported that UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) were working on a divestment package to satisfy regulator concerns over antitrust violations.
Capitol Forum had previously reported that Amedisys was aiming to offload more than 100 of its locations to a “private equity-backed buyer.”
On Friday, Capitol Forum reported that the buyer had walked away from the deal, leaving Amedisys without a divestment partner. Amedisys stock dropped over 5% as of Friday afternoon, after the news surfaced.
“Amedisys shares were weak today after a report from Capitol Forum … suggesting that talks have fallen through between AMED/UNH and the PE-backed potential buyer of the company’s home health assets that need to be divested as...
Today's Sponsors
Today's Sponsor